Sherbrooke Park Advisers’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
ACH
SCM
WA
AC
Sherbrooke Park Advisers's AXGN Position: Q3 2025 in Review
Sherbrooke Park Advisers sold out of Axogen (AXGN) in Q3 2025, closing a stake of 12,241 shares — an estimated $133K sold.
Sherbrooke Park Advisers first reported a position in AXGN in Q3 2023 and held it in 3 quarters. The position peaked at $142K in Q4 2023. 171 funds tracked by Wall St. Rank hold AXGN as of Q3 2025.
- Sherbrooke Park Advisers reported no remaining Axogen position as of Q3 2025 after selling out during the quarter.
- Sherbrooke Park Advisers sold 12,241 Axogen shares in Q3 2025, an estimated $133K.
- Sherbrooke Park Advisers first reported a position in Axogen in Q3 2023 and held it in 3 quarters.
- Sherbrooke Park Advisers's Axogen position peaked at $142K in Q4 2023.
- 171 funds tracked by Wall St. Rank held Axogen as of Q3 2025.
Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.